Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. AnaptysBio Inc shares valued at $200,714 were sold by RENTON HOLLINGS on Aug 08 ’25. At $19.62 per share, RENTON HOLLINGS sold 10,231 shares. The insider’s holdings dropped to 4,965 shares worth approximately $0.1 million following the completion of this transaction.
Also, HOLLINGS C RENTON purchased 10,231 shares, netting a total of over 200,713 in proceeds.
Before that, RENTON HOLLINGS had sold 20,925 shares from its account. In a trade valued at $493,191, the Director traded AnaptysBio Inc shares for $23.57 each. Upon closing the transaction, the insider’s holdings decreased to 20,925 shares, worth approximately $0.1 million.
As published in a research note from H.C. Wainwright on June 04, 2025, AnaptysBio Inc [ANAB] has been rated up from a Neutral to a Buy and the price target has been revised to $38. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of December 11, 2024, H.C. Wainwright has decreased its “Buy” rating to a “Neutral” for ANAB. Earlier on December 02, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for ANAB stock which previously was a “a Buy”.
Analyzing ANAB Stock Performance
On last trading session, AnaptysBio Inc [NASDAQ: ANAB] rose 1.04% to $20.36. The stock’s lowest price that day was $19.6001, but it reached a high of $20.545 in the same session. During the last five days, there has been a surge of approximately 1.95%. Over the course of the year, AnaptysBio Inc shares have dropped approximately -44.14%. Shares of the company reached a 52-week high of $28.50 on 07/24/25 and a 52-week low of $12.21 on 02/11/25.
Support And Resistance Levels for AnaptysBio Inc (ANAB)
According to the 24-hour chart, there is a support level at 19.78, which, if violated, would cause prices to drop to 19.21. In the upper region, resistance lies at 20.75. The next price resistance is at 21.15. RSI (Relative Strength Index) is 35.41 on the 14-day chart, showing neutral technical sentiment.
Is AnaptysBio Inc subject to short interest?
Stocks of AnaptysBio Inc saw a sharp rise in short interest on 2025-07-31 jumping by 0.2 million shares to 9.56 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 9.36 million shares. A jump of 2.09% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 18.41 of the overall float, the days-to-cover ratio (short ratio) jumped to 18.41.
Which companies own the most shares of AnaptysBio Inc (ANAB)?
In terms of AnaptysBio Inc share price expectations, FactSet research, analysts set an average price target of 54 in the next 12 months, up nearly 167.99% from the previous closing price of $20.15. Analysts anticipate AnaptysBio Inc stock to reach 54 by 2025, with the lowest price target being 54. In spite of this, 6 analysts ranked AnaptysBio Inc stock as Buy at the end of 2025. On July 22, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $55.
